- Release Date: 11/03/24 08:55
- Summary: New case of SCENESSE efficacy in vitiligo presented at AAD
- Price Sensitive: Yes
- Download Document 362.39KB
Ann: New case of SCENESSE efficacy in vitiligo presented at AAD
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.78 |
Change
0.190(1.30%) |
Mkt cap ! $725.6M | |||
| Open | High | Low | Value | Volume |
| $14.76 | $14.96 | $14.46 | $770.9K | 52.43K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 222 | $14.73 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.76 | 112 | 6 |
View Market Depth
| Last trade - 13.40pm 31/07/2024 (20 minute delay) ? |
| CUV (ASX) Chart |